World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   7635 records for 1274 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not AvailableEUCTR2015-003999-79-Outside-EU/EEA
An open-label, ascending, repeated, dose-finding study of Sarilumab in children and adolescents with polyarticular-course juvenile idiopathic arthritis (pcJIA)
08/04/2016
AuthorisedEUCTR2015-001154-14-EE
Comparison of Vonoprazan to Esomeprazole in Subjects with Symptomatic GERD Who Responded Partially to a High Dose of PPI 21/03/2016
Not recruitingNCT02722603
Study to Compare Gabapentin to Tramadol in Children
18/03/2016
RecruitingRBR-93gkd4
Efficacy and safety of Eslicarbazepine Acetate (BIA 2-093) as single therapy for patients with newly diagnosed partial-onset seizures - ESL extension study
11/03/2016
AuthorisedEUCTR2014-004048-36-HU
This study is to determine if ranibizumab injected into the eye is superior to laser therapy in the treatment of retinopathy of prematurity (ROP). The study will assess the ability of these treatments to lead to regression of active ROP and prevent the development of ocular complications that are associated with poor visual outcome.
10/03/2016
RecruitingNCT02706951
A Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) Monotherapy in Subjects With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)
18/02/2016
RecruitingNCT02706847
A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
18/02/2016
AuthorisedEUCTR2015-004068-13-LV
Study investigating PEGylated Recombinant Human Hyaluronidase (PEGPH20) in previously untreated patients with pancreatic cancer that have high levels of hyaluronan. The study has two groups: all patients will be treated with nab-Paclitaxel plus Gemcitabine. In addition, one group will receive PEGPH20 and the other group will receive an inactive substance. Neither the patient nor the doctor will know the treatment group in which the patient has been randomly assigned to. 16/02/2016
AuthorisedEUCTR2015-003782-28-DK
A study to determine the efficacy and safety of fasinumab for the treatment of adults with lower back pain
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-003782-28-PLA study to determine the efficacy and safety of fasinumab for the treatment of adults with lower back pain18/02/2016
AuthorisedEUCTR2015-003782-28-HUA study to determine the efficacy and safety of fasinumab for the treatment of adults with lower back pain12/04/2016
08/02/2016
AuthorisedEUCTR2015-001778-17-FI
A long-term follow-up study (ZOE-LTFU) of two studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to assess the efficacy, safety, and immunogenicity persistence of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine and assessment of 1 or 2 additional doses in two subgroups of older adults. 04/02/2016
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history